Boehringer Ingelheim BioXcellence
Ingelheim am Rhein, Germany
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (10)
○ EMA GMP
○ MHRA GMP
Quick Facts: Boehringer Ingelheim BioXcellence
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Ingelheim am Rhein, Germany
- Modalities
- Monoclonal Antibody, Bispecific Antibody, Recombinant Protein, Antibody Fragments, Biosimilars, Biologics
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Boehringer Ingelheim BioXcellence
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesMonoclonal Antibody, Bispecific Antibody, Recombinant Protein, Antibody Fragments, Biosimilars, Biologics
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (6 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press10 articles
Broad modality coverage (6 modalities)
Recent News 10 articles
Boehringer Ingelheim signs gene therapy manufacturing deal with AnGes - European Pharmaceutical Review
HGF gene therapy product - Boehringer Ingelheim
2025 capacity update | BioXcellence - Boehringer Ingelheim
Rezon Bio appoints Dr. Ralf Otto as Chief Operating Officer to support next phase of growth and operational expansion - Manufacturing Chemist
Sutro Biopharma collaboration first-in-class cell-free capabilities - Boehringer Ingelheim
Boehringer, AnGes sign agreement for drug manufacturing - Pharmaceutical Technology
Antibody and Recombinant Protein CDMO Market Analysis and Forecast 2024-2031 - Insightace Analytic
Producing Value with Boehringer Ingelheim BioXcellence™ August 2014 - BioProcess International
CDMO insights 2025 | BioXcellence - Boehringer Ingelheim
Biotechnology expert joins CDMO - European Biotechnology Magazine
Frequently Asked Questions About Boehringer Ingelheim BioXcellence
What is Boehringer Ingelheim BioXcellence's CDMO Signal Score?
Boehringer Ingelheim BioXcellence has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Boehringer Ingelheim BioXcellence for a manufacturing program?
Use the free AI matchmaker to compare Boehringer Ingelheim BioXcellence against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Mabion S.A.
Konstantynów Łódźki, Poland
Monoclonal Antibody, Recombinant Protein, Biosimilars, Vaccine Antigens, ADC / PDC (analytics & development), Sterile Fill-Finish
EirGenix
Zhubei City, Hsinchu County, Taiwan
Monoclonal Antibody, Bispecific/Polyclonal Antibody, Recombinant Protein, ADC, Biosimilars, Plasmid DNA
Rentschler Biopharma
Laupheim, Germany
Signal Score: 79.9
Monoclonal Antibody, Recombinant Protein
KBI Biopharma
Durham, NC · Boulder, CO
Signal Score: 83.5
Monoclonal Antibody, Recombinant Protein, AAV, Plasmid DNA
Catalent
Bagsværd, Denmark (operating under Novo Holdings)
Signal Score: 76.5
Monoclonal Antibody, Recombinant Protein, ADC, AAV, mRNA, Plasmid DNA, Fill-Finish